Based on those results, we used statin, an inhibitor for mevalonate pathway rate-limiting enzyme HMG-CoA reductase, in drinking water to prevent WD accompanied hypercholesterolemia in our training model (Figure S5A). Here, HMGCR is linked to Hypercholesterolemia.